白血病抑制因子通过增加粘附分子和冠毛素1的表达同时降低组织金属蛋白酶抑制剂的表达从而增加了滋养层细胞的侵袭性
Leukemia inhibitory factor increases the invasiveness of trophoblastic cells through integrated increase in the expression of adhesion molecules and pappalysin 1 with a concomitant decrease in the expression of tissue inhibitor of matrix metalloproteinases
Pankaj Suman, Ph.D., Nachiket Shembekar, M.Sc., Satish Kumar Gupta, Ph.D.
Objective
To identify the invasion-associated molecules during leukemia inhibitory factor–(LIF-)mediated increase in the invasion of trophoblast cells.
Design
Experimental study.
Setting
Research institution.
Patient(s)
None.
Intervention(s)
Cultured trophoblastic HTR-8/SVneo cells were treated with LIF.
Main Outcome Measure(s)
Matrigel matrix-based invasion assay of HTR-8/SVneo cells. Signaling molecules associated with LIF-mediated increase in invasion were investigated by Western blot, cDNA microarray, quantitative reverse transcriptase polymerase chain reaction, immunofluorescence, immunohistochemistry, and gene silencing by siRNA.
Result(s)
Treatment of HTR-8/SVneo cells with LIF (50 ng/mL) led to a significant increase in invasion. Treatment with LIF also led to an increase in nuclear localization of activated STAT1 and STAT3. Among 237 differentially expressed genes after LIF treatment, expression of pappalysin 1, SERPINB3, podoplanin, integrin β3, ID1, ICAM1, and so on went up, while tissue inhibitor of matrix metalloproteinase 1 (TIMP1), TIMP2, and TIMP3 went down significantly. The presence of several of these proteins has also been demonstrated in human trophoblast cells. Silencing of pappalysin 1 led to a significant reduction in basal as well as LIF-mediated invasiveness of HTR-8/SVneo cells.
Conclusion(s)
Identification of novel molecules associated with a LIF-mediated increase in trophoblastic cell invasion may facilitate our understanding of implantation biology.
Fertility and Sterility
Volume 99, Issue 2 , Pages 533-542.e2, February 2013
copyright© 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号